0001209191-23-023078.txt : 20230404
0001209191-23-023078.hdr.sgml : 20230404
20230404201819
ACCESSION NUMBER: 0001209191-23-023078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Milligan Sandra
CENTRAL INDEX KEY: 0001859810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 23800767
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001821825
Organon & Co.
OGN
0001859810
Milligan Sandra
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07302
0
1
0
0
Head of Research & Development
0
Common Stock
2023-03-31
4
M
0
5964
0.00
A
26825
D
Common Stock
2023-03-31
4
F
0
2115
23.09
D
24710
D
Restricted Stock Units
2023-03-31
4
M
0
5964
0.00
D
Common Stock
5964
11928
D
Restricted Stock Units
2023-03-31
4
A
0
29230
0.00
A
2024-03-31
2026-03-31
Common Stock
29230
29230
D
Stock Option (right to buy)
23.52
2023-03-31
4
A
0
104961
0.00
A
2024-03-31
2033-03-31
Common Stock
104961
104961
D
Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025.
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU.
These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.
The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
2023-04-04